Carregant...
Decitabine: a historical review of the development of an epigenetic drug
The development of decitabine from its synthesis in 1964 to the submission of a registration file has been described. Although the unique DNA-demethylating capacity of decitabine is known for a long time, its application is under continuing investigation. The use of decitabine in MDS, AML, CML, stem...
Guardat en:
| Publicat a: | Ann Hematol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer-Verlag
2005
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7103145/ https://ncbi.nlm.nih.gov/pubmed/16220311 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00277-005-0008-x |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|